{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "29374248", "DateCompleted": {"Year": "2018", "Month": "12", "Day": "18"}, "DateRevised": {"Year": "2018", "Month": "12", "Day": "18"}, "Article": {"ArticleDate": [{"Year": "2018", "Month": "01", "Day": "26"}], "Language": ["eng"], "ELocationID": ["1698", "10.1038/s41598-018-20083-z"], "Journal": {"ISSN": "2045-2322", "JournalIssue": {"Volume": "8", "Issue": "1", "PubDate": {"Year": "2018", "Month": "Jan", "Day": "26"}}, "Title": "Scientific reports", "ISOAbbreviation": "Sci Rep"}, "ArticleTitle": "Role of Quzhou Fructus Aurantii Extract in Preventing and Treating Acute Lung Injury and Inflammation.", "Pagination": {"StartPage": "1698", "MedlinePgn": "1698"}, "Abstract": {"AbstractText": ["Quzhou Fructus Aurantii (QFA) is an authentic herb of local varieties in Zhejiang, China, which is usually used to treat gastrointestinal illnesses, but its effects on respiratory inflammation have not been reported yet. In our study, the anti-inflammatory activity of QFA extract (QFAE) was evaluated on copper sulfate pentahydrate (CuSO<sub>4</sub>\u00b75H<sub>2</sub>O)-induced transgenic neutrophil fluorescent zebrafish model. QFAE showed a significant effect of anti-inflammation in CuSO<sub>4</sub>\u00b75H<sub>2</sub>O-induced zebrafish by reducing the neutrophil number in the inflammatory site. We investigated the anti-inflammatory activity of QFAE on lipopolysaccharide (LPS)-induced acute lung injury (ALI) mice models and RAW 264.7 cells. QFAE had an anti-inflammatory effect on reducing total cells, neutrophils, and macrophages in BALF and attenuated alveolus collapse, neutrophils infiltration, lung W/D ratio, myeloperoxidase (MPO) protein expression and other pulmonary histological changes in lung tissues, as well as hematological changes. Levels of pro-inflammatory cytokines, including TNF, IL-6, IFN-\u03b3, MCP-1, and IL-12p70, were decreased, whereas anti-inflammatory cytokine IL-10 was increased after treatment with QFAE both in vivo and in vitro. In summary, our results suggested that QFAE had apparent anti-inflammatory effects on CuSO<sub>4</sub>\u00b75H<sub>2</sub>O-induced zebrafish, LPS-induced ALI mice, and RAW 264.7 cells. Furthermore, QFAE may be a therapeutic drug to treat ALI/ARDS and other respiratory inflammations."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Collaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals, Zhejiang University of Technology, Hangzhou, Zhejiang, China."}, {"Identifier": [], "Affiliation": "State Key Laboratory of Safety Evaluation for New Drugs, Zhejiang Academy of Medical Sciences, Hangzhou, Zhejiang, China."}], "LastName": "Li", "ForeName": "Lili", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Safety Evaluation for New Drugs, Zhejiang Academy of Medical Sciences, Hangzhou, Zhejiang, China."}], "LastName": "Zhang", "ForeName": "Sheng", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Safety Evaluation for New Drugs, Zhejiang Academy of Medical Sciences, Hangzhou, Zhejiang, China."}], "LastName": "Xin", "ForeName": "Yanfei", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Animal Health, Guangdong Academy of Agricultural Sciences, Guangzhou, Guangdong, China."}], "LastName": "Sun", "ForeName": "Junying", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Safety Evaluation for New Drugs, Zhejiang Academy of Medical Sciences, Hangzhou, Zhejiang, China."}], "LastName": "Xie", "ForeName": "Feng", "Initials": "F"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Collaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals, Zhejiang University of Technology, Hangzhou, Zhejiang, China."}, {"Identifier": [], "Affiliation": "State Key Laboratory of Safety Evaluation for New Drugs, Zhejiang Academy of Medical Sciences, Hangzhou, Zhejiang, China."}], "LastName": "Yang", "ForeName": "Lin", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Safety Evaluation for New Drugs, Zhejiang Academy of Medical Sciences, Hangzhou, Zhejiang, China."}], "LastName": "Chen", "ForeName": "Zhiqin", "Initials": "Z"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Safety Evaluation for New Drugs, Zhejiang Academy of Medical Sciences, Hangzhou, Zhejiang, China."}], "LastName": "Chen", "ForeName": "Hao", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Safety Evaluation for New Drugs, Zhejiang Academy of Medical Sciences, Hangzhou, Zhejiang, China."}], "LastName": "Liu", "ForeName": "Fang", "Initials": "F"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Collaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals, Zhejiang University of Technology, Hangzhou, Zhejiang, China."}, {"Identifier": [], "Affiliation": "State Key Laboratory of Safety Evaluation for New Drugs, Zhejiang Academy of Medical Sciences, Hangzhou, Zhejiang, China."}], "LastName": "Xuan", "ForeName": "Yaoxian", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Safety Evaluation for New Drugs, Zhejiang Academy of Medical Sciences, Hangzhou, Zhejiang, China. youzhenqiang0817@163.com."}], "LastName": "You", "ForeName": "Zhenqiang", "Initials": "Z"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Sci Rep", "NlmUniqueID": "101563288", "ISSNLinking": "2045-2322"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Anti-Inflammatory Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Cytokines"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}], "MeshHeadingList": [{"QualifierName": ["prevention & control"], "DescriptorName": "Acute Lung Injury"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": [], "DescriptorName": "Animals, Genetically Modified"}, {"QualifierName": ["administration & dosage", "isolation & purification"], "DescriptorName": "Anti-Inflammatory Agents"}, {"QualifierName": ["cytology"], "DescriptorName": "Bronchoalveolar Lavage Fluid"}, {"QualifierName": [], "DescriptorName": "China"}, {"QualifierName": ["analysis"], "DescriptorName": "Cytokines"}, {"QualifierName": [], "DescriptorName": "Disease Models, Animal"}, {"QualifierName": ["pathology"], "DescriptorName": "Lung"}, {"QualifierName": ["drug effects"], "DescriptorName": "Macrophages"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": ["administration & dosage", "isolation & purification"], "DescriptorName": "Plant Extracts"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["prevention & control"], "DescriptorName": "Pneumonia"}, {"QualifierName": [], "DescriptorName": "RAW 264.7 Cells"}, {"QualifierName": [], "DescriptorName": "Treatment Outcome"}, {"QualifierName": [], "DescriptorName": "Zebrafish"}], "CoiStatement": "The authors declare that they have no competing interests."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Frantzeskaki F, Armaganidis A, Orfanos SE. Immunothrombosis in acute respiratory distress syndrome: cross talks between inflammation and coagulation. Respiration. 2017;93:212\u2013225. doi: 10.1159/000453002.", "ArticleIdList": ["10.1159/000453002", "27997925"]}, {"Citation": "Matsuo, S., Sharma, A., Wang, P. & Yang, W. L. PYR-41, a ubiquitin-activating enzyme E1 inhibitor, attenuates lung injury in sepsis. Shock. (2017).", "ArticleIdList": ["PMC5745315", "28661933"]}, {"Citation": "Li W, An X, Fu M, Li C. Emergency treatment and nursing of children with severe pneumonia complicated by heart failure and respiratory failure: 10 case reports. Exp. Ther. Med. 2016;12:2145\u20132149. doi: 10.3892/etm.2016.3558.", "ArticleIdList": ["10.3892/etm.2016.3558", "PMC5038202", "27698703"]}, {"Citation": "Hu PJ, Pittet JF, Kerby JD, Bosarge PL, Wagener BM. Acute brain trauma, lung injury and pneumonia: more than just altered mental status and decreased airway protection. Am. J. Physiol-Lung Cell. Mol. Physiol. 2017;313:L1\u2013L15. doi: 10.1152/ajplung.00485.2016.", "ArticleIdList": ["10.1152/ajplung.00485.2016", "28408366"]}, {"Citation": "Matthay MA, Ware LB, Zimmerman GA. The acute respiratory distress syndrome. J. Clin. Invest. 2012;122:2731\u20132740. doi: 10.1172/JCI60331.", "ArticleIdList": ["10.1172/JCI60331", "PMC3408735", "22850883"]}, {"Citation": "Wheeler AP, Bernard GR. Bernard G R. Acute lung injury and the acute respiratory distress syndrome: a clinical review. Lancet. 2007;369:1553\u20131564. doi: 10.1016/S0140-6736(07)60604-7.", "ArticleIdList": ["10.1016/S0140-6736(07)60604-7", "17482987"]}, {"Citation": "Standiford TJ, Ward PA. Therapeutic targeting of acute lung injury and acute respiratory distress syndrome. Transl. Res. 2016;167:183\u2013191. doi: 10.1016/j.trsl.2015.04.015.", "ArticleIdList": ["10.1016/j.trsl.2015.04.015", "PMC4635065", "26003524"]}, {"Citation": "Butt Y, Kurdowska A, Allen TC. Acute lung injury: a clinical and molecular review. Arch. Pathol. Lab. Med. 2016;140:345\u2013350. doi: 10.5858/arpa.2015-0519-RA.", "ArticleIdList": ["10.5858/arpa.2015-0519-RA", "27028393"]}, {"Citation": "Raghavendran K, et al. Pharmacotherapy of acute lung injury and acute respiratory distress syndrome. Curr. Med. Chem. 2008;15:1911\u20131924. doi: 10.2174/092986708785132942.", "ArticleIdList": ["10.2174/092986708785132942", "PMC2636692", "18691048"]}, {"Citation": "Kneyber MCJ, Markhorst DG. Management of acute lung injury and acute respiratory distress syndrome in children: a different perspective. Crit. Care Med. 2009;37:3191\u20133192. doi: 10.1097/CCM.0b013e3181bc7a18.", "ArticleIdList": ["10.1097/CCM.0b013e3181bc7a18", "19923955"]}, {"Citation": "Xu L, et al. Pharmacodynamic comparison of Qi Regulating and Depression Dispersing between Citrus Changshan-Huyou and Aurantii Fructus from different sources. Chinese Journal of Experimental Traditional Medical Formulae. 2016;22:156\u2013160."}, {"Citation": "Guo Z, Li W, Li Z. Determination of naringin and neohesperidin in Aurantii Fructus from different habitats. Chinese Traditional and Herbal Drugs. 2012;43:1347\u20131348."}, {"Citation": "Su MS, Shyu YT, Chien PJ. Antioxidant activities of citrus herbal product extracts. Food Chem. 2008;111:892\u2013896. doi: 10.1016/j.foodchem.2008.05.002.", "ArticleIdList": ["10.1016/j.foodchem.2008.05.002"]}, {"Citation": "Wang L, Zhang JZ, Gao WY. Anti-inflammatory activity of Weichang\u2019an Pill. Chinese Traditional and Herbal Drugs. 2013;44:1017\u20131021."}, {"Citation": "He W, et al. Zhizhu decoction promotes gastric emptying and protects the gastric mucosa. J. Med. Food. 2013;16:306\u2013311. doi: 10.1089/jmf.2012.2438.", "ArticleIdList": ["10.1089/jmf.2012.2438", "23566057"]}, {"Citation": "Kang M, et al. Anti-ischemic effect of Aurantii Fructus on contractile dysfunction of ischemic and reperfused rat heart. J. Ethnopharmacol. 2007;111:584\u2013591. doi: 10.1016/j.jep.2007.01.007.", "ArticleIdList": ["10.1016/j.jep.2007.01.007", "17291701"]}, {"Citation": "Bradley PP, Christensen RD, Rothstein G. Cellular and extracellular myeloperoxidase in pyogenic inflammation. Blood. 1982;60:618\u2013622.", "ArticleIdList": ["6286012"]}, {"Citation": "Lau D, Baldus S. Myeloperoxidase and its contributory role in inflammatory vascular disease. Pharmacol. Ther. 2006;111:16\u201326. doi: 10.1016/j.pharmthera.2005.06.023.", "ArticleIdList": ["10.1016/j.pharmthera.2005.06.023", "16476484"]}, {"Citation": "Li P, et al. Comparison of Aurantii Fructus Immaturus and Aurantii Fructus based on multiple chromatographic analysis and chemometrics methods. J. Chromatogr. A. 2016;1469:96\u2013107. doi: 10.1016/j.chroma.2016.09.061.", "ArticleIdList": ["10.1016/j.chroma.2016.09.061", "27717489"]}, {"Citation": "Ma C, et al. Identification of chemical constituents in extracts and rat plasma from Fructus Aurantii by UPLC-PDA-Q-TOF/MS. Phytochem. Anal. 2011;22:112\u2013118. doi: 10.1002/pca.1252.", "ArticleIdList": ["10.1002/pca.1252", "21259373"]}, {"Citation": "Ye, X. D. et al. Rapid and sensitive LC-MS/MS method for the determination of auraptene in rat plasma and its application in a pharmacokinetic and bioavailability study in rats. Genet. Mol. Res. 15 (2016).", "ArticleIdList": ["27420975"]}, {"Citation": "Gopinath K, Sudhandiran G. Naringin modulates oxidative stress and inflammation in 3-nitropropionic acid-induced neurodegeneration through the activation of nuclear factor-erythroid 2-related factor-2 signalling pathway. Neuroscience. 2012;227:134\u2013143. doi: 10.1016/j.neuroscience.2012.07.060.", "ArticleIdList": ["10.1016/j.neuroscience.2012.07.060", "22871521"]}, {"Citation": "Mahmoud AM, Ashour MB, Abdel-Moneim A, Ahmed OM. Hesperidin and naringin attenuate hyperglycemia-mediated oxidative stress and proinflammatory cytokine production in high fat fed/streptozotocin-induced type 2 diabetic rats. J. Diabetes Complica. 2012;26:483\u2013490. doi: 10.1016/j.jdiacomp.2012.06.001.", "ArticleIdList": ["10.1016/j.jdiacomp.2012.06.001", "22809898"]}, {"Citation": "Jain M, Parmar HS. Evaluation of antioxidative and anti-inflammatory potential of hesperidin and naringin on the rat air pouch model of inflammation. Inflamm. Res. 2011;60:483\u2013491. doi: 10.1007/s00011-010-0295-0.", "ArticleIdList": ["10.1007/s00011-010-0295-0", "21181230"]}, {"Citation": "Wu Q, et al. p-Synephrine suppresses lipopolysaccharide-induced acute lung injury by inhibition of the NF-\u03baB signaling pathway. Inflamm. Res. 2014;63:429\u2013439. doi: 10.1007/s00011-014-0715-7.", "ArticleIdList": ["10.1007/s00011-014-0715-7", "24487736"]}, {"Citation": "Funaguchi N, et al. Narirutin inhibits airway inflammation in an allergic mouse model. Clin. Exp. Pharmacol. Physiol. 2007;34:766\u2013770. doi: 10.1111/j.1440-1681.2007.04636.x.", "ArticleIdList": ["10.1111/j.1440-1681.2007.04636.x", "17600554"]}, {"Citation": "Shi Q, et al. Artificial sweetener neohesperidin dihydrochalcone showed antioxidative, anti-inflammatory and anti-apoptosis effects against paraquat-induced liver injury in mice. Int. Immunopharmacol. 2015;29:722\u2013729. doi: 10.1016/j.intimp.2015.09.003.", "ArticleIdList": ["10.1016/j.intimp.2015.09.003", "26362205"]}, {"Citation": "Murakami A, et al. Inhibitory effect of citrus nobiletin on phorbol ester-induced skin inflammation, oxidative stress, and tumor promotion in mice. Cancer Res. 2000;60:5059\u20135066.", "ArticleIdList": ["11016629"]}, {"Citation": "Zon LI, Peterson RT. In vivo drug discovery in the zebrafish. Nat. Rev. Drug Discov. 2005;4:35\u201344. doi: 10.1038/nrd1606.", "ArticleIdList": ["10.1038/nrd1606", "15688071"]}, {"Citation": "MacRae CA, Peterson RT. Zebrafish as tools for drug discovery. Nat. Rev. Drug Discov. 2015;14:721\u2013731. doi: 10.1038/nrd4627.", "ArticleIdList": ["10.1038/nrd4627", "26361349"]}, {"Citation": "Howe K, et al. The zebrafish reference genome sequence and its relationship to the human genome. Nature. 2013;496:498\u2013503. doi: 10.1038/nature12111.", "ArticleIdList": ["10.1038/nature12111", "PMC3703927", "23594743"]}, {"Citation": "Lieschke GJ, Currie PD. Animal models of human disease: zebrafish swim into view. Nat. Rev. Genet. 2007;8:353\u2013367. doi: 10.1038/nrg2091.", "ArticleIdList": ["10.1038/nrg2091", "17440532"]}, {"Citation": "D\u2019Alencon CA, et al. A high-throughput chemically induced inflammation assay in zebrafish. BMC Biol. 2010;8:151. doi: 10.1186/1741-7007-8-151.", "ArticleIdList": ["10.1186/1741-7007-8-151", "PMC3022775", "21176202"]}, {"Citation": "Zhang Y, et al. Manipulating the air-filled zebrafish swim bladder as a neutrophilic inflammation model for acute lung injury. Cell Death Dis. 2016;7:e2470. doi: 10.1038/cddis.2016.365.", "ArticleIdList": ["10.1038/cddis.2016.365", "PMC5260887", "27831560"]}, {"Citation": "Pereira TC, Campos MM, Bogo MR. Copper toxicology, oxidative stress and inflammation using zebrafish as experimental model. J. Appl. Toxicol. 2016;36:876\u2013885. doi: 10.1002/jat.3303.", "ArticleIdList": ["10.1002/jat.3303", "26888422"]}, {"Citation": "Rougier F, Froutaud D, Ndoye A, Deschaux P. Non-specific immune response ofZebrafish, Brachydanio rerio, (Hamilton-Buchanan) following copper and zinc exposure . Fish Shellfish Immun. 1994;4:115\u2013127. doi: 10.1006/fsim.1994.1010.", "ArticleIdList": ["10.1006/fsim.1994.1010"]}, {"Citation": "Wittmann, C. et al. Facilitating drug discovery: an automated high-content inflammation assay in zebrafish. J. Vis. Exp. e4203 (2012).", "ArticleIdList": ["PMC3476412", "22825322"]}, {"Citation": "Leite CE, et al. Involvement of purinergic system in inflammation and toxicity induced by copper in zebrafish larvae. Toxicol. Appl. Pharm. 2013;272:681\u2013689. doi: 10.1016/j.taap.2013.08.001.", "ArticleIdList": ["10.1016/j.taap.2013.08.001", "23933163"]}, {"Citation": "Hernandez PP, et al. Sublethal concentrations of waterborne copper induce cellular stress and cell death in zebrafish embryos and larvae. Biol. Res. 2011;44:7\u201315. doi: 10.4067/S0716-97602011000100002.", "ArticleIdList": ["10.4067/S0716-97602011000100002", "21720676"]}, {"Citation": "Huang YT, et al. Fructus aurantii reduced portal pressure in portal hypertensive rats. Life Sci. 1995;57:2011\u20132020. doi: 10.1016/0024-3205(95)02195-O.", "ArticleIdList": ["10.1016/0024-3205(95)02195-O", "7475952"]}, {"Citation": "Wan, X., Wei, Y., Cheng, X., Liu, X. & Luo, L. Clinical observation of Fructus Aurantii Immaturus and Fructus Aurantii in compound in treatment of coronary heart disease. Guangdong Trace Elements Science. (2017)."}, {"Citation": "Wang S, et al. Mechanism of fructus aurantii flavonoids promoting gastrointestinal motility: From organic and inorganic endogenous substances combination point of view. Pharmacogn. Mag. 2017;13:372\u2013377. doi: 10.4103/pm.pm_179_16.", "ArticleIdList": ["10.4103/pm.pm_179_16", "PMC5551352", "28839359"]}, {"Citation": "Jiang Y, Bai X, Zhu X, Li J. The effects of Fructus Aurantii extract on the 5-hydroxytryptamine and vasoactive intestinal peptide contents of the rat gastrointestinal tract. Pharm. Biol. 2014;52:581\u2013585. doi: 10.3109/13880209.2013.854396.", "ArticleIdList": ["10.3109/13880209.2013.854396", "24707973"]}, {"Citation": "Huang W, et al. Meranzin hydrate induces similar effect to Fructus Aurantii on intestinal motility through activation of H1 histamine receptors. J. Gastrointest. Surg. 2011;15:87\u201396. doi: 10.1007/s11605-010-1374-9.", "ArticleIdList": ["10.1007/s11605-010-1374-9", "21061180"]}, {"Citation": "Qin X, et al. Micheliolide inhibits LPS-induced inflammatory response and protects mice from LPS challenge. Sci. Rep. 2016;6:23240. doi: 10.1038/srep23240.", "ArticleIdList": ["10.1038/srep23240", "PMC4794649", "26984741"]}, {"Citation": "Xie X, et al. Zingerone attenuates lipopolysaccharide-induced acute lung injury in mice. Int. Immunopharmacol. 2014;19:103\u2013109. doi: 10.1016/j.intimp.2013.12.028.", "ArticleIdList": ["10.1016/j.intimp.2013.12.028", "24412620"]}, {"Citation": "Zheng XF, et al. Lipopolysaccharide-induced M2 to M1 macrophage transformation for IL-12p70 production is blocked by Candida albicans mediated up-regulation of EBI3 expression. PLoS One. 2013;8:e63967. doi: 10.1371/journal.pone.0063967.", "ArticleIdList": ["10.1371/journal.pone.0063967", "PMC3664618", "23724011"]}, {"Citation": "Ware LB, Matthay MA. The acute respiratory distress syndrome. New Engl. J. Med. 2000;342:1334\u20131349. doi: 10.1056/NEJM200005043421806.", "ArticleIdList": ["10.1056/NEJM200005043421806", "10793167"]}, {"Citation": "Rubenfeld GD, et al. Incidence and outcomes of acute lung injury. New Engl. J. Med. 2005;353:1685\u20131693. doi: 10.1056/NEJMoa050333.", "ArticleIdList": ["10.1056/NEJMoa050333", "16236739"]}, {"Citation": "Ware LB. Pathophysiology of acute lung injury and the acute respiratory distress syndrome. Semin. Resp. Crit. Care Med. 2006;27:337\u2013349. doi: 10.1055/s-2006-948288.", "ArticleIdList": ["10.1055/s-2006-948288", "16909368"]}, {"Citation": "Morty RE, Eickelberg O, Seeger W. Alveolar fluid clearance in acute lung injury: what have we learned from animal models and clinical studies? Intensive Care Med. 2007;33:1229\u20131240. doi: 10.1007/s00134-007-0662-7.", "ArticleIdList": ["10.1007/s00134-007-0662-7", "PMC7095514", "17525842"]}, {"Citation": "Odenstedt H, Aneman A, Karason S, Stenqvist O, Lundin S. Acute hemodynamic changes during lung recruitment in lavage and endotoxin-induced ALI. Intensive Care Med. 2005;31:112\u2013120. doi: 10.1007/s00134-004-2496-x.", "ArticleIdList": ["10.1007/s00134-004-2496-x", "15605230"]}, {"Citation": "Neumann P, Berglund JE, Mondejar EF, Magnusson A, Hedenstierna G. Effect of different pressure levels on the dynamics of lung collapse and recruitment in oleic-acid\u2013induced lung injury. Am. J. Respir. Crit. Care Med. 1998;158:1636\u20131643. doi: 10.1164/ajrccm.158.5.9711095.", "ArticleIdList": ["10.1164/ajrccm.158.5.9711095", "9817719"]}, {"Citation": "Vadasz I, et al. Oleic acid inhibits alveolar fluid reabsorption: a role in acute respiratory distress syndrome? Am. J. Respir. Crit. Care Med. 2005;171:469\u2013479. doi: 10.1164/rccm.200407-954OC.", "ArticleIdList": ["10.1164/rccm.200407-954OC", "15542790"]}, {"Citation": "Raetz CRH, Whitfield C. Lipopolysaccharide endotoxins. Annu. Rev. Biochem. 2002;71:635\u2013700. doi: 10.1146/annurev.biochem.71.110601.135414.", "ArticleIdList": ["10.1146/annurev.biochem.71.110601.135414", "PMC2569852", "12045108"]}, {"Citation": "Chen H, Bai C, Wang X. The value of the lipopolysaccharide-induced acute lung injury model in respiratory medicine. Expert Rev. Respir. Med. 2010;4:773\u2013783. doi: 10.1586/ers.10.71.", "ArticleIdList": ["10.1586/ers.10.71", "21128752"]}, {"Citation": "Winterbourn C, Vissers MA. Myeloperoxidase. Curr. Opin. Hematol. 2000;7:53\u201358. doi: 10.1097/00062752-200001000-00010.", "ArticleIdList": ["10.1097/00062752-200001000-00010", "10608505"]}, {"Citation": "Loria V, Dato I, Graziani F, Biasucci LM. Myeloperoxidase: a new biomarker of inflammation in ischemic heart disease and acute coronary syndromes. Mediators Inflamm. 2008;2008:135625. doi: 10.1155/2008/135625.", "ArticleIdList": ["10.1155/2008/135625", "PMC2276594", "18382609"]}, {"Citation": "Podrez EA, Abu-Soud HM, Hazen SL. Myeloperoxidase-generated oxidants and atherosclerosis. Free Radic. Biol. Med. 2000;28:1717\u20131725. doi: 10.1016/S0891-5849(00)00229-X.", "ArticleIdList": ["10.1016/S0891-5849(00)00229-X", "10946213"]}, {"Citation": "Haegens A, et al. Myeloperoxidase deficiency attenuates lipopolysaccharide-induced acute lung inflammation and subsequent cytokine and chemokine production. J. Immunol. 2009;182:7990\u20137996. doi: 10.4049/jimmunol.0800377.", "ArticleIdList": ["10.4049/jimmunol.0800377", "19494324"]}, {"Citation": "Krawisz JE, Sharon P, Stenson WF. Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Gastroenterology. 1984;87:1344\u20131350.", "ArticleIdList": ["6092199"]}]}], "History": [{"Year": "2017", "Month": "10", "Day": "3"}, {"Year": "2018", "Month": "1", "Day": "10"}, {"Year": "2018", "Month": "1", "Day": "28", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "1", "Day": "28", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "12", "Day": "19", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "1", "Day": "26"}], "PublicationStatus": "epublish", "ArticleIdList": ["29374248", "PMC5785969", "10.1038/s41598-018-20083-z", "10.1038/s41598-018-20083-z"]}}]}